Centre de transplantation d'organes

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


550 publications

... | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ...
 
New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.
Beckmann S., Denhaerynck K., Stampf S., Saigi-Morgui N., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group, Swiss Transplant Cohort Study, 2018/11. Transplant international, 31 (11) pp. 1254-1267. Peer-reviewed.
 
Efficient B cell Depletion With Rituximab Despite Massive Proteinuria.
Halfon M., Pascual M., Aubert V., Rotman S., Yannick M.D., 2018/10. Transplantation, 102 (10) pp. e401-e402. Peer-reviewed.
 
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M., Rettby N., Perreau M., Pascual M., Pantaleo G., Manuel O., 2018/10/01. Vaccine, 36 (41) pp. 6163-6169. Peer-reviewed.
 
Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe.
Coussement J., Maggiore U., Manuel O., Scemla A., López-Medrano F., Nagler E.V., Aguado J.M., Abramowicz D., European Renal Association-European Dialysis Transplant Association (ERA-EDTA) Developing Education Science and Care for Renal Transplantation in European States (DESCARTES) working group and the European Study Group for Infections in Compromised Hosts (E, COLLABORATORS (IN ALPHABETICAL ORDER) et al., 2018/09/01. Nephrology, dialysis, transplantation, 33 (9) pp. 1661-1668. Peer-reviewed.
 
Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei N., Koutsokera A., Pasquier J., Mombelli M., Meylan P., Pascual M., Aubert J.D., Manuel O., 2018/08. Transplant infectious disease, 20 (4) pp. e12893. Peer-reviewed.
 
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Neofytos D., Chatzis O., Nasioudis D., Boely Janke E., Doco Lecompte T., Garzoni C., Berger C., Cussini A., Boggian K., Khanna N. et al., 2018/08. Transplant infectious disease, 20 (4) pp. e12898. Peer-reviewed.
Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
Cusini A., Béguelin C., Stampf S., Boggian K., Garzoni C., Koller M., Manuel O., Meylan P., Mueller N.J., Hirsch H.H. et al., 2018/07. American journal of transplantation, 18 (7) pp. 1745-1754. Peer-reviewed.
Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.
Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M., 2018/06. Transplantation, 102 (6) pp. e301-e303. Peer-reviewed.
 
Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective.
Aguado J.M., Manuel O., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S1. Peer-reviewed.
 
Biomarkers of immune tolerance in liver transplantation.
Vionnet J., Sánchez-Fueyo A., 2018/05. Human immunology, 79 (5) pp. 388-394. Peer-reviewed.
 
Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation.
Vionnet J., Yerly P., Aubert J.D., Pascual M., Aldenkortt F., Berney T., Giostra E., Moradpour D., Schiffer E., 2018/05. Transplantation, 102 (5) pp. e194. Peer-reviewed.
Targeted γ-secretase inhibition of Notch signaling activation in acute renal injury.
Wyss J.C., Kumar R., Mikulic J., Schneider M., Aebi J.D., Juillerat-Jeanneret L., Golshayan D., 2018/05/01. American journal of physiology. Renal physiology, 314 (5) pp. F736-F746. Peer-reviewed.
 
Xenotransplantation: back to the future?
Meier RPH, Muller Y.D., Balaphas A., Morel P., Pascual M., Seebach J.D., Buhler L.H., 2018/05. Transplant international, 31 (5) pp. 465-477. Peer-reviewed.
 
LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.
Yu K., Davidson C.L., Wójtowicz A., Lisboa L., Wang T., Airo A.M., Villard J., Buratto J., Sandalova T., Achour A. et al., 2018/04/02. The Journal of clinical investigation, 128 (4) pp. 1523-1537. Peer-reviewed.
 
Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism.
Coquoz N., Weilenmann D., Stolz D., Popov V., Azzola A., Fellrath J.M., Stricker H., Pagnamenta A., Ott S., Ulrich S. et al., 2018/04. The European respiratory journal, 51 (4) pp. pii: 1702505. Peer-reviewed.
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Muller Y.D., Ghaleb N., Rotman S., Vionnet J., Halfon M., Catana E., Golshayan D., Venetz J.P., Aubert V., Pascual M., 2018/04. Transplant international, 31 (4) pp. 451-455. Peer-reviewed.
 
Immune Monitoring for CMV in Transplantation.
Yong M.K., Lewin S.R., Manuel O., 2018/03/14. Current infectious disease reports, 20 (4) p. 4. Peer-reviewed.
Microbial metagenome of urinary tract infection.
Moustafa A., Li W., Singh H., Moncera K.J., Torralba M.G., Yu Y., Manuel O., Biggs W., Venter J.C., Nelson K.E. et al., 2018/03/12. Scientific reports, 8 (1) p. 4333. Peer-reviewed.
First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
Daccord C., Letovanec I., Yerly P., Bloch J., Ogna A., Nicod L.P., Aubert J.D., 2018/03. The European respiratory journal, 51 (3) pp. 1-4. Peer-reviewed.
 
Retour en dialyse après transplantation rénale : une étude rétrospective dans le canton de Vaud [Return to dialysis after kidney transplantation: a retrospective study in the Canton de Vaud]
Pedrazzini B., Golshayan D., Teta D., 2018/02/21. Revue medicale suisse, 14 (595) pp. 430-434. Peer-reviewed.
 
Lung transplantation after allogeneic stem cell transplantation: a pan-European experience.
Greer M., Berastegui C., Jaksch P., Benden C., Aubert J., Roux A., Lhuillier E., Hirschi S., Reynaud-Gaubert M., Philit F. et al., 2018/02. The European respiratory journal, 51 (2) pp. NA. Peer-reviewed.
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.
López-Medrano F., Fernández-Ruiz M., Silva J.T., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2018/02. Clinical microbiology and infection, 24 (2) pp. 192-198. Peer-reviewed.
 
Use of oscillometric devices in atrial fibrillation: a comparison of three devices and invasive blood pressure measurement.
Halfon M., Wuerzner G., Marques-Vidal P., Taffe P., Vaucher J., Waeber B., Liaudet L., Ltaief Z., Popov M., Waeber G., 2018/02. Blood pressure, 27 (1) pp. 48-55. Peer-reviewed.
 
Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors.
Stucchi RSB, Lopes M.H., Kumar D., Manuel O., 2018/02. Transplantation, 102 (2S Suppl 2) pp. S72-S80. Peer-reviewed.
Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature.
Libudzic-Nowak A.M., Cachat F., Pascual M., Chehade H., 2018. Frontiers in pediatrics, 6 p. 398. Peer-reviewed.
Extended-criteria donors in lung transplantation in Switzerland: an evaluation of two adapted lung donor scores.
Elmer A., Birrer M., Weiss J., Aubert J.D., Benden C., Inci I., Krüger T., Soccal P.M., Immer F.F., 2018. Swiss medical weekly, 148 pp. w14614. Peer-reviewed.
Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
Steiner R., Kridel R., Giostra E., McKee T., Achermann R., Mueller N., Manuel O., Dickenmann M., Schuurmans M.M., de Leval L. et al., 2018. Swiss medical weekly, 148 pp. w14596. Peer-reviewed.
 
Preeclampsia and Long-term Renal Function in Women Who Underwent Kidney Transplantation.
Vannevel V., Claes K., Baud D., Vial Y., Golshayan D., Yoon E.W., Hodges R., Le Nepveu A., Kerr P.G., Kennedy C. et al., 2018/01. Obstetrics and gynecology, 131 (1) pp. 57-62. Peer-reviewed.
 
Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B., Fegbeutel C., Silveira F.P., Verschuuren E.A., Younus M., Mo J., Yan J., Ussetti P., Chin-Hong P.V., Solé A. et al., 2018/01. American journal of transplantation, 18 (1) pp. 113-124. Peer-reviewed.
 
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
Navarro D., San-Juan R., Manuel O., Giménez E., Fernández-Ruiz M., Hirsch H.H., Grossi P.A., Aguado J.M., ESGICH CMV Survey Study Group on behalf of the European Study Group of Infections in Compromised Hosts (ESGICH) from the Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2017/12. Transplant infectious disease, 19 (6) p. 1. Peer-reviewed.
 
Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.
Gero D., Dib F., Matter M., Pascual M., Venetz J.P., Demartines N., Melloul E., 2017/11. World journal of surgery, 41 (11) pp. 2940-2948. Peer-reviewed.
 
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation [PLB069]
Muller Y, Ghaleb N., Rotman S, Catana E., Golshayan D, Venetz JP, Aubert V., Pascual M., 2017/10/31. pp. 553-554 dans Transplant International.
BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.
Leboeuf C., Wilk S., Achermann R., Binet I., Golshayan D., Hadaya K., Hirzel C., Hoffmann M., Huynh-Do U., Koller M.T. et al., 2017/10. American journal of transplantation, 17 (10) pp. 2591-2600. Peer-reviewed.
Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
Juillerat-Jeanneret L., Tafelmeyer P., Golshayan D., 2017/10. Expert opinion on therapeutic targets, 21 (10) pp. 977-991. Peer-reviewed.
 
Early acute antibody-mediated rejection (AMR) after lung transplantation successfully treated with c5 blockade [PLB032]
Muller Y., Aubert JD, Vionnet J., Rotman S., Aubert V, Pascual M., 2017/09/30. pp. 543-543 dans Transplant International.
 
Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
Vionnet J., Pascual M., Testoni B., Combet C., Godat S., Vijgen S., Aubert V., Rubbia-Brandt L., Zoulim F., Moradpour D., 2017/09/16. Hepatology, 67 (2) pp. 791-793 . Peer-reviewed.
 
The impact of multidisciplinary care on early morbidity and mortality after heart transplantation.
Schmidhauser M., Regamey J., Pilon N., Pascual M., Rotman S., Banfi C., Prêtre R., Meyer P., Antonietti J.P., Hullin R., 2017/09/01. Interactive cardiovascular and thoracic surgery, 25 (3) pp. 384-390. Peer-reviewed.
 
Syndrome hépato-pulmonaire et hypertension porto-pulmonaire [Hepatopulmonary syndrome and portopulmonary hypertension]
Marcu C., Schiffer E., Aubert J.D., Vionnet J., Yerly P., Deltenre P., Marot A., 2017/08/30. Revue medicale suisse, 13 (572) pp. 1464-1469. Peer-reviewed.
 
A 58-Year-Old Man With Position-Dependent Nocturnal Dyspnea.
Schertel A., Horvath C.M., Pichler Hefti J., Aubert J.D., Brill A.K., 2017/08. Chest, 152 (2) pp. e51-e55. Peer-reviewed.
Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants.
Gaildrat P., Lebbah S., Tebani A., Sudrié-Arnaud B., Tostivint I., Bollee G., Tubeuf H., Charles T., Bertholet-Thomas A., Goldenberg A. et al., 2017/07. Molecular genetics & genomic medicine, 5 (4) pp. 373-389. Peer-reviewed.
Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C., Stampf S., Héquet D., Mueller N.J., Cusini A., van Delden C., Khanna N., Boggian K., Hirzel C., Soccal P. et al., 2017/07. American journal of transplantation, 17 (7) pp. 1813-1822. Peer-reviewed.
 
Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation.
Simonetta F., Pradier A., Masouridi-Levrat S., van Delden C., Giostra E., Morard I., Mueller N., Muellhaupt B., Valli P.V., Semmo N. et al., 2017/07. Transplantation, 101 (7) pp. e219-e221. Peer-reviewed.
 
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.
Lebeaux D., Freund R., van Delden C., Guillot H., Marbus S.D., Matignon M., Van Wijngaerden E., Douvry B., De Greef J., Vuotto F. et al., 2017/05/15. Clinical infectious diseases, 64 (10) pp. 1396-1405. Peer-reviewed.
 
Evolution of body weight parameters up to 3 years after solid organ transplantation: The prospective Swiss Transplant Cohort Study.
Beckmann S., Nikolic N., Denhaerynck K., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group Swiss Transplant Cohort Study, 2017/03. Clinical transplantation, 31 (3). Peer-reviewed.
 
ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study.
Mauthner O., Claes V., Walston J., Engberg S., Binet I., Dickenmann M., Golshayan D., Hadaya K., Huynh-Do U., Calciolari S. et al., 2017/03. Journal of advanced nursing, 73 (3) pp. 716-734. Peer-reviewed.
Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.
Beaume M., Köhler T., Greub G., Manuel O., Aubert J.D., Baerlocher L., Farinelli L., Buckling A., van Delden C., Swiss Transplant Cohort Study, 2017/01/17. Scientific reports, 7 p. 40309. Peer-reviewed.
 
A Renal Paratransplant Hernia Causing Complete Small Bowel Obstruction: A Case Report and Review of the Literature.
Zingg T., Teixeira Farinha H., Demartines N., Pascual M., Matter M., 2017. Transplantation proceedings, 49 (1) pp. 210-212. Peer-reviewed.
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J. et al., 2017/01. The pharmacogenomics journal, 17 (1) pp. 69-75. Peer-reviewed.
Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.
Koutsokera A., Royer P.J., Antonietti J.P., Fritz A., Benden C., Aubert J.D., Tissot A., Botturi K., Roux A., Reynaud-Gaubert M.L. et al., 2017. Frontiers in medicine, 4 p. 109. Peer-reviewed.
IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice.
Govender L., Wyss J.C., Kumar R., Pascual M., Golshayan D., 2017. Frontiers in immunology, 8 p. 421. Peer-reviewed.
Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study.
Franzen D.P., Nowak A., Haile S.R., Mottet D., Bonani M., Dormond O., Kohler M., Krayenbuehl P.A., Barbey F., 2017. PloS one, 12 (7) pp. e0180437. Peer-reviewed.
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.
Obregon C., Kumar R., Pascual M.A., Vassalli G., Golshayan D., 2017. Frontiers in immunology, 8 p. 1514. Peer-reviewed.
 
Blockade of C5 in Severe Acute Postinfectious Glomerulonephritis Associated With Anti-Factor H Autoantibody.
Chehade H., Rotman S., Frémeaux-Bacchi V., Aubert V., Sadallah S., Sifaki L., Salomon R., Pascual M., 2016/12. American journal of kidney diseases : the official journal of the National Kidney Foundation, 68 (6) pp. 944-948. Peer-reviewed.
 
Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.
López-Medrano F., Fernández-Ruiz M., Silva J.T., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2016/11. American journal of transplantation, 16 (11) pp. 3220-3234. Peer-reviewed.
Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.
Opota O., Balmpouzis Z., Berutto C., Kaiser-Guignard J., Greub G., Aubert J.D., Prod'hom G., Manuel O., Jaton K., 2016/10. Transplant infectious disease, 18 (5) pp. 801-804. Peer-reviewed.
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
Kumar R., Juillerat-Jeanneret L., Golshayan D., 2016/09/08. Journal of medicinal chemistry, 59 (17) pp. 7719-7737. Peer-reviewed.
 
Chronic Lung Allograft Dysfunction : A Systematic Review of Mechanisms
Royer Pierre-Joseph, Olivera-Botello Gustavo, Koutsokera Angela, Aubert John-David, Bernasconi Eric, Tissot Adrien, Pison Christophe, Nicod Laurent, Boissel Jean-Pierre, Magnan Antoine, 2016/09. Transplantation, 100 (9) pp. 1803-1814.
 
Oral valganciclovir for CMV gastritis.
Saouli A.C., Salvade I., Saldarriaga J., Manuel O., Venetz J.P., Golshayan D., Sempoux C., Pascual M., 2016/09. Clinics and research in hepatology and gastroenterology, 40 (4) pp. e50-1. Peer-reviewed.
 
Amyloïdose héréditaire à transthyrétine [Transthyretin-related hereditary amyloidosis]
Vionnet J., Pascual M., Kuntzer T., Yerly P., Moradpour D., 2016/08/31. Revue medicale suisse, 12 (528) pp. 1434-1440. Peer-reviewed.
 
HIV-Positive-to-HIV-Positive Liver Transplantation.
Calmy A., van Delden C., Giostra E., Junet C., Rubbia Brandt L., Yerly S., Chave J.P., Samer C., Elkrief L., Vionnet J. et al., 2016/08. American journal of transplantation, 16 (8) pp. 2473-2478. Peer-reviewed.
 
Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study.
Coussement J., Lebeaux D., van Delden C., Guillot H., Freund R., Marbus S., Melica G., Van Wijngaerden E., Douvry B., Van Laecke S. et al., 2016/08/01. Clinical infectious diseases, 63 (3) pp. 338-345. Peer-reviewed.
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.
Tschan-Plessl A., Stern M., Schmied L., Retière C., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C. et al., 2016/07. Transplantation direct, 2 (7) pp. e89. Peer-reviewed.
Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patients.
Rello J., Manuel O., Eggimann P., Richards G., Wejse C., Petersen J.E., Zacharowski K., Leblebicioglu H., ESGCIP and ESGITM, 2016/07. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 48 pp. 104-112. Peer-reviewed.
 
Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
Héquet D., Pascual M., Lartey S., Pathirana R.D., Bredholt G., Hoschler K., Hullin R., Meylan P., Cox R.J., Manuel O., 2016/06/30. Vaccine, 34 (31) pp. 3576-3583. Peer-reviewed.
 
Non-Hodgkin lymphoma and idiopathic inflammatory cardiomyopathy.
Rutz T., Prior J.O., Vionnet J., Pruvot E., 2016/06/14. European heart journal, 37 (23) p. 1859. Peer-reviewed.
 
Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Salvadé I., Aubert V., Venetz J.P., Golshayan D., Saouli A.C., Matter M., Rotman S., Pantaleo G., Pascual M., 2016/06. Human immunology, 77 (6) pp. 483-489. Peer-reviewed.
 
Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions.
Pellegrin M., Szostak J., Bouzourène K., Aubert J.F., Berthelot A., Nussberger J., Laurant P., Mazzolai L., 2016/04/30. Journal of cardiovascular pharmacology and therapeutics, 22 (2) pp. 159-168. Peer-reviewed.
 
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
Golshayan D., Wójtowicz A., Bibert S., Pyndiah N., Manuel O., Binet I., Buhler L.H., Huynh-Do U., Mueller T., Steiger J. et al., 2016/04. Kidney international, 89 (4) pp. 927-938. Peer-reviewed.
 
Bloodstream infections after solid-organ transplantation.
Kritikos A., Manuel O., 2016. Virulence, 7 (3) pp. 329-340. Peer-reviewed.
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis.
Aubert J.D., Juillerat-Jeanneret L., 2016. Journal of Medicinal Chemistry, 59 (18) pp. 8168-8188. Peer-reviewed.
 
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
Vijgen S., Wyss C., Meylan P., Bisig B., Letovanec I., Manuel O., Pascual M., de Leval L., 2016. Transplantation, 100 (1) pp. 134-140. Peer-reviewed.
Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?
Michaud L., Ludwig G., Berney S., Rodrigues S., Niquille A., Santschi V., Favre A.S., Lange A.C., Michels A.A., Vrijens B. et al., 2016. Pharmacy practice, 14 (4) p. 822. Peer-reviewed.
Microbial Communities of Conducting and Respiratory Zones of Lung-Transplanted Patients.
Beaume M., Lazarevic V., Köhler T., Gaïa N., Manuel O., Aubert J.D., Baerlocher L., Farinelli L., Gasche P., Schrenzel J. et al., 2016. Frontiers in microbiology, 7 p. 1749. Peer-reviewed.
Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts.
Lorent M., Giral M., Pascual M., Koller M.T., Steiger J., Trébern-Launay K., Legendre C., Kreis H., Mourad G., Garrigue V. et al., 2016. Plos One, 11 (5) pp. e0155278. Peer-reviewed.
Presence of Chlamydiales DNA in samples negative by broad-range bacterial 16S rRNA PCRs: new insights into chlamydial pathogenic role.
Tagini F., Jaton K., Manuel O., Greub G., 2016. New Microbes and New Infections, 11 pp. 32-33. Peer-reviewed.
 
Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study.
López-Medrano F., Silva J.T., Fernández-Ruiz M., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2016. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 16 (7) pp. 2148-2157. Peer-reviewed.
 
The Challenge of Acute Antibody-Mediated Rejection in Kidney Transplantation.
Chehade H., Pascual M., 2016. Transplantation, 100 (2) pp. 264-265. Peer-reviewed.
 
Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease.
Vionnet J., Saouli A.C., Pascual M., Stucker F., Decosterd L.A., Moradpour D., Chtioui H., 2016. Journal of Hepatology, 65 (5) pp. 1063-1065. Peer-reviewed.
Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
Héquet D., Kralidis G., Carrel T., Cusini A., Garzoni C., Hullin R., Meylan P.R., Mohacsi P., Mueller N.J., Ruschitzka F. et al., 2016. Bmc Infectious Diseases, 16 p. 321. Peer-reviewed.
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Wojtowicz A., Bibert S., Beckmann S., Mueller N.J., Binet I. et al., 2016. PloS one, 11 (10) pp. e0164443. Peer-reviewed.
 
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Hirsch H. et al., 2015/08/15. Clinical infectious diseases, 61 (4) pp. 619-622. Peer-reviewed.
 
Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity.
Roehrich M.E., Wyss J.C., Kumar R., Pascual M., Golshayan D., Vassalli G., 2015. Immunopharmacology and Immunotoxicology, 37 (5) pp. 434-441. Peer-reviewed.
 
All regulators great and small: when Treg need small RNAs to fulfill their commitment.
Golshayan D., 2015. Transplant International : Official Journal of the European Society For Organ Transplantation, 28 (10) pp. 1140-1142.
 
Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy.
Halfon M., Rotman S., Egli M., Venetz J.P., Pascual M., 2015. Acta Diabetologica, 52 (6) pp. 1175-1177. Peer-reviewed.
 
Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient.
Chehade H., Rotman S., Matter M., Girardin E., Aubert V., Pascual M., 2015. Pediatrics, 135 (2) pp. e551-e555. Peer-reviewed.
 
Fabry disease in a geriatric population.
Barbey F., Joly D., Noel E., Drouineau O., Krayenbühl P.A., Lidove O., 2015. Clinical Genetics, 88 (5) pp. 499-501. Peer-reviewed.
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
Manuel O., Wójtowicz A., Bibert S., Mueller N.J., van Delden C., Hirsch H.H., Steiger J., Stern M., Egli A., Garzoni C. et al., 2015. Journal of Infectious Diseases, 211 (6) pp. 906-914.
 
Le rôle des associations de patients face au don d'organes en Suisse romande [Organ donation and the role of patients' associations in Western Switzerland].
Kaech F., Barras V., Pascual M., Hammer R., 2015. Revue Médicale Suisse, 11 (496) pp. 2250-2253.
 
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.
Schmied L., Terszowski G., Gonzalez A., Schmitter K., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C. et al., 2015. Transplantation, 99 (12) pp. 2651-2655. Peer-reviewed.
 
Pulmonary arterial hypertension in patients treated with interferon.
Prella M., Yerly P., Nicod L.P., Aubert J.D., 2015. European Respiratory Journal, 46 (6) pp. 1849-1851. Peer-reviewed.
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.
Biegstraaten M., Arngrímsson R., Barbey F., Boks L., Cecchi F., Deegan P.B., Feldt-Rasmussen U., Geberhiwot T., Germain D.P., Hendriksz C. et al., 2015. Orphanet Journal of Rare Diseases, 10 (1) p. 36. Peer-reviewed.
Reply to Cunha et al.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Khanna N. et al., 2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (12) pp. 1894-1895. Peer-reviewed.
Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.
Vionnet J., Pascual M., Chtioui H., Giostra E., Majno P.E., Decosterd L.A., Moradpour D., 2015. BMC Gastroenterology, 15 (1) p. 38. Peer-reviewed.
 
Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal Diseases.
Juillerat-Jeanneret L., Flohr A., Schneider M., Walter I., Wyss J.C., Kumar R., Golshayan D., Aebi J.D., 2015. Journal of Medicinal Chemistry, 58 (20) pp. 8097-8109. Peer-reviewed.
 
The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation.
Martin-Gandul C., Mueller N.J., Pascual M., Manuel O., 2015. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 15 (12) pp. 3024-3040.
 
Time-Dependent Specificity of Immunopathologic (C4d-CD68) and Histologic Criteria of Antibody-Mediated Rejection for Donor-Specific Antibodies and Allograft Dysfunction in Heart Transplantation.
Yerly P., Rotman S., Nobile A., Aubert V., Tozzi P., Yarol N., Vogt P., Hullin R., Pascual M., 2015. Transplantation, 99 (3) pp. 586-593.
 
Transition en transplantation rénale [Transition in kidney transplantation].
Chehade H., Parvex P., Venetz J.P., Hadaya K., Typaldou S.A., Villard E., Vogeleisen C., Pilon N., Cachat F., Pascual M., 2015. Revue Médicale Suisse, 11 (462) pp. 456, 458-456, 460. Peer-reviewed.
 
Treatment of pulmonary arterial hypertension: an update
Prella maura, Yerly Patrick, Aubert John-David, 2014/11/19. Cardiovascular Medicine, 17 (11) pp. 334-343.
 
Vaccin contre le zona: quelles recommandations en 2014?
Vionnet Julien, Hart Karen, Spertini François, 2014/04/16. Revue médicale suisse.
Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling.
Kumar R., Clerc A.C., Gori I., Russell R., Pellegrini C., Govender L., Wyss J.C., Golshayan D., Canny G.O., 2014/02. Plos One, 9 (2) pp. e89742. Peer-reviewed.
 
A special issue on infections in solid organ transplant recipients.
Gavaldà J., Aguado J.M., Manuel O., Grossi P., Hirsch H.H., ESCMID Study Group of Infection in Compromised Hosts, 2014. Clinical Microbiology and Infection, 20 (Suppl 7) pp. 1-3.
 
Cytomegalovirus infection in solid organ transplant recipients
Lumbreras C., Manuel O., Len O., ten Berge I.J.M., Sgarabotto D., Hirsch H.H, 2014. Clinical Microbiology and Infection, 20 pp. 19-26.
 
Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment.
Stern M., Hirsch H., Cusini A., van Delden C., Manuel O., Meylan P., Boggian K., Mueller N.J., Dickenmann M., all members of the Swiss Transplant Cohort Study, 2014. Transplantation, 98 (9) pp. 1013-1018. Peer-reviewed.
 
Does the intermed instrument predict medication adherence in transplant recipients?
Schneider Marie P., Ludwig Gundula, Rodrigues Stephanie, Niquille Anne, Santschi Valerie, Lange Anne-Catherine, Favre Anne-Sophie, Bugnon Olivier, Pascual Manuel, Michaud Laurent et al., 2014. dans 18th Annual ESPACOMP Meeting.
 
Facteurs influençant le retour au travail après transplantation chez 61 patients rénaux ou hépatiques
Praz-Christinaz Sophie-Maria, Pascual Manuel, Pilon Nathalie, Simcox Amira, Wild Pascal, Danuser Brigitta, 2014. Revue Médicale Suisse, 10 (431) pp. 1148-1152. Peer-reviewed.
 
Heart donation after circulatory determination of death: ethically acceptable?
Dalle Ave A.L., Shaw D.M., Pascual M., Benaroyo L., 2014. Nature Reviews. Cardiology, 11 (9) p. 553. Peer-reviewed.
 
Hepatitis C Virus Infection and Kidney Transplantation in 2014: What's New?
Baid-Agrawal S., Pascual M., Moradpour D., Somasundaram R., Muche M., 2014. American Journal of Transplantation, 14 (10) pp. 2206-2220.
 
Histological and immunological aspects of chronic skin allograft rejection
Rotman S., Aubert V., Koch N., Raffoul W., Pascual M., 2014. dans 80th annual congress of the Swiss Society of Pathology.
 
Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F., Pascual M., Hullin R., Yerly P., Tozzi P., Meylan P., Manuel O., 2014. Transplantation, 97 (11) pp. 1192-1197.
 
In reply to 'beneficial effect of eculizumab on thrombotic microangiopathies: another point of view'.
Schmidtko J., Peine S., 2014. American Journal of Kidney Diseases, 63 (1) p. 167.
 
Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study.
Bridevaux P.O., Aubert J.D., Soccal P.M., Mazza-Stalder J., Berutto C., Rochat T., Turin L., Belle S.V., Nicod L., Meylan P. et al., 2014. Thorax, 69 (1) pp. 32-38. Peer-reviewed.
 
Infections cutanées causées par des mycobactéries à croissance rapide [Skin infections due to rapid-growing mycobacteria].
Gervais P., Manuel O., Jaton K., Giulieri S., 2014. Revue Médicale Suisse, 10 (427) pp. 931-934.
Influenza and other respiratory virus infections in solid organ transplant recipients
Manuel O., López-Medrano F., Kaiser L., Welte T., Carrataià J., Cordero E., Hirsch H.H, 2014. Clinical Microbiology and Infection, 20 pp. 102-108.
 
Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
Vermeiren P., Aubert V., Sugamele R., Aubert J.D., Venetz J.P., Meylan P., Pascual M., Manuel O., 2014. Transplant International, 27 (9) pp. 903-908.
 
Influenza vaccination in immunocompromised patients: efficacy and safety.
Zbinden D., Manuel O., 2014. Immunotherapy, 6 (2) pp. 131-139.
 
KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.
Gonzalez A., Schmitter K., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C., Villard J., Manuel O. et al., 2014. Genes and Immunity, 15 (7) pp. 495-499. Peer-reviewed.
Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
Jaworski M., Marsland B.J., Gehrig J., Held W., Favre S., Luther S.A., Perroud M., Golshayan D., Gaide O., Thome M., 2014. EMBO Journal, 33 (23) pp. 2765-2781.
 
No major impact of skin aging on the response of skin blood flow to a submaximal local thermal stimulus.
Vionnet J., Calero-Romero I., Heim A., Rotaru C., Engelberger R.P., Dischl B., Noël B., Liaudet L., Waeber B., Feihl F., 2014. Microcirculation, 21 (8) pp. 730-737. Peer-reviewed.
 
Potential and limitations of regulatory T-cell therapy in solid organ transplantation.
Govender L., Pascual M., Golshayan D., 2014. Expert Review of Clinical Immunology, 10 (9) pp. 1197-1212.
 
Réduction de volume pulmonaire dans l'emphysème sévère: importance d'une prise en charge multidisciplinaire [Lung volume reduction (LVR) in severe emphysema: a multidisciplinary approach].
Lovis A., Krueger T., Perentes J.Y., Ris H.B., Egger B., Beigelman C., Nicod L., Aubert J.D., Gonzalez M., 2014. Revue Médicale Suisse, 10 (435) pp. 1337-1342. Peer-reviewed.
 
Transcatheter aortic valve implantation in a lung transplant recipient.
Brill A.K., Gloekler S., Aubert J.D., Wenaweser P.M., Geiser T., 2014. Annals of Thoracic Surgery, 97 (6) pp. e159-e160. Peer-reviewed.
 
Un cas inhabituel d'allergie au champagne [A case of unusual allergy to champagne].
Carron P.N., Vionnet J., Ribi C., Pasquier M., Hugli O., 2014. Presse Médicale, 43 (10 Pt 1) pp. 1127-1129. Peer-reviewed.
 
Allergies aux produits de contraste radiologiques [Allergy to radiographic contrast media].
Vionnet J., Petitpierre S., Fumeaux A., Meuli R., Spertini F., Comte D., 2013. Revue Médicale Suisse, 9 (382) pp. 812-818.
 
Approche interdisciplinaire de la decision de don d'organes: l'experience lausannoise [An interdisciplinary approach of the organ donation decision: the Lausanne's experience].
Bosisio F., Merminod G., Burger M., Pascual M., Moretti D., Benaroyo L., 2013. Revue Médicale Suisse, 9 (408) pp. 2249-2253.
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study.
Manuel O., Husain S., Kumar D., Zayas C., Mawhorter S., Levi M.E., Kalpoe J., Lisboa L., Ely L., Kaul D.R. et al., 2013. Clinical Infectious Diseases, 56 (6) pp. 817-824.
Clinical Experience with Immune Monitoring for Cytomegalovirus in Solid-Organ Transplant Recipients.
Manuel O., 2013. Current Infectious Disease Reports, 15 (6) pp. 491-496. Peer-reviewed.
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.
Koller M.T., van Delden C., Müller N.J., Baumann P., Lovis C., Marti H.P., Fehr T., Binet I., De Geest S., Bucher H.C. et al., 2013. European Journal of Epidemiology, 28 (4) pp. 347-355.
 
European survey on the management of tuberculosis in solid-organ transplant recipients and candidates.
Boillat-Blanco N., Aguado J.M., Aubert J.D., Sester M., Grossi P., Kamar N., Pascual M., Manuel O., ESCMID Study Group of Infection in Compromised Hosts (ESGICH), 2013. Transplant International, 26 (8) pp. e69-e70. Peer-reviewed.
 
Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs.
Perrottet N., Aubert V., Venetz J.P., Ugolini E., Matter M., Pannatier A., Pascual M., 2013. Transplantation, 95 (5) pp. e24-e25.
 
Glucosurie rénale [Renal glucosuria].
Rohfleisch A., Nseir G., Chehade H., Noverraz M.G., Venetz J.P., Barbey F., 2013. Revue Médicale Suisse, 9 (378) pp. 636-640.
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
Manuel O., Kralidis G., Mueller N.J., Hirsch H.H., Garzoni C., van Delden C., Berger C., Boggian K., Cusini A., Koller M.T. et al., 2013. American Journal of Transplantation, 13 (9) pp. 2402-2410.
 
Liver Transplantation for Neuroendocrine Tumors in Europe-Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study.
Le Treut Y.P., Grégoire E., Klempnauer J., Belghiti J., Jouve E., Lerut J., Castaing D., Soubrane O., Boillot O., Mantion G. et al., 2013. Annals of Surgery, 257 (5) pp. 807-815.
 
Phenytoin-associated severe hypocalcemia with seizures in a patient with a TSC2-PKD1 contiguous gene syndrome.
Nseir G., Golshayan D., Barbey F., 2013. Renal Failure, 35 (6) pp. 866-868. Peer-reviewed.
 
Prévention des infections chez les voyageurs immunosupprimés [Prevention of infection in immunocompromised travelers].
Zbinden D., D'Acremont V., Manuel O., 2013. Revue Médicale Suisse, 9 (385) pp. 958-962.
 
Pulmonary involvement in Fabry disease: Overview and perspectives.
Franzen D., Krayenbuehl P.A., Lidove O., Aubert J.D., Barbey F., 2013. European Journal of Internal Medicine, 24 (8) pp. 707-713.
 
RNA respiratory viruses in solid organ transplantation.
Manuel O., Estabrook M., T Infectious Diseases Community of Practice, 2013. American Journal of Transplantation, 13 (Suppl. 4) pp. 212-219.
 
Thoracic aortic dilation/aneurysm in fabry disease.
Dormond O., Barbey F., 2013. American Journal of Medicine, 126 (12) pp. e23.
 
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.
Schmidtko J., Peine S., El-Housseini Y., Pascual M., Meier P., 2013. American Journal of Kidney Diseases, 61 (2) pp. 289-299. Peer-reviewed.
 
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.
Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Danziger-Isakov L., Humar A., Transplantation Society International CMV Consensus Group, 2013. Transplantation, 96 (4) pp. 333-360.
 
Relevance of cohort studies for the study of transplant infectious diseases.
Berger C., Boggian K., Cusini A., van Delden C., Garzoni C., Hirsch H.H., Khanna N., Koller M., Manuel O., Meylan P. et al., 2012/12. Current opinion in organ transplantation, 17 (6) pp. 581-585. Peer-reviewed.
 
MR imaging as a specific diagnostic tool for bilateral microcysts in chronic lithium nephropathy.
Golshayan D., Nseir G., Venetz J.P., Pascual M., Barbey F., 2012/03. Kidney International, 81 (6) p. 601. Peer-reviewed.
Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease.
Friedrich L., Barbey F., Pascual M., Venetz J.P., 2012. Case Reports in Transplantation, 2012 p. 513025.
 
Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient.
Chehade H., Girardin E., Delich V., Pascual M.A., Venetz J.P., Cachat F., 2012. Transplant Infectious Disease, 14 (4) pp. E27-E29.
 
Antimicrobial Agents
Csajka C., Marchetti O., Manuel O., Decosterd L., Telenti A., 2012. pp. 379-402 dans Anzenbacher P., Zanger U.M. (eds.) Metabolism of Drugs and Other Xenobiotics chap. 14, Wiley-VCH Verlag.
 
Effects of immunosuppressive drugs on T helper cells subsets and potential to promote tolerance in a stringent experimental transplantation model.
Wyss J.C., Govender L., Pascual M., Golshayan D., 2012. pp. 462-463 dans American Transplant Congress 2012, American Journal of Transplantation. Peer-reviewed.
 
Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.
Manuel O., Baid-Agrawal S., Moradpour D., Pascual M., 2012. Contributions to Nephrology, 176 pp. 97-107.
 
Impact of Anti-T-Cell Therapy in the Immunogenicity of Seasonal Influenza Vaccine in Kidney Transplant Recipients.
Orcurto A., Pascual M., Hoschler K., Aubert V., Meylan P., Manuel O., 2012. Transplantation, 94 (6) pp. 630-636. Peer-reviewed.
 
Influenza vaccination in solid-organ transplant recipients.
Cordero E., Manuel O., 2012. Current Opinion In Organ Transplantation, 17 (6) pp. 601-608. Peer-reviewed.
 
Integrated Analysis of High-Resolution Gene Expression and Copy Number Profiling Identified Biallelic Deletion of CDKN2A/2B Tumor Suppressor Locus As the Most Frequent and Unique Genomic Abnormality in Diffuse Large B-Cell Lymphoma (DLBCL) with Strong Prognostic Value in Both GCB and ABC Subtypes and Not Overcome by a Dose-Intensive Immunochemotherapy Regimen Plus Rituximab. Results of a Prospective GELA Clinical Trial Program
Jardin F., Mareschal S., Figeac M., Jais J.P., Leroy K., Copie-Bergman C., Salles G.A., Coiffier B., Delarue R., Peyrade F. et al., 2012. pp. Abstract 415 dans ASH 2012, 54th Annual Meeting of the American Society of Hematology, Blood.
Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient
Renard D., Gauthier T., Venetz J.-P., Buclin T., Kuntzer T., 2012. Clinical Kidney Journal, 5 (4) pp. 323-326. Peer-reviewed.
 
Potential of T-regulatory cells to protect xenografts.
Muller Y.D., Ehirchiou D., Golshayan D., Buhler L.H., Seebach J.D., 2012. Current Opinion in Organ Transplantation, 17 (2) pp. 155-161. Peer-reviewed.
 
Rejets aigus
Venetz J.P., Pascual M., 2012. pp. 449-464 dans Legendre C. (eds.) Transplantation Rénale chap. 38, Médecine Sciences Publications.
 
Role of intra-operative duplex ultrasound in living renal donor transplantation
Bejic M., Deglise S., Nseir G., Saucy F., Matter M., Meuwly J.Y., Corpataux J.M., 2012. pp. 20-21 dans 99th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery.
 
Strength and limitations of regulatory T Cells for immunotherapy in transplantation.
Govender L., Wyss J.C., Pascual M., Golshayan D., 2012. p. 448 dans American Transplant Congress 2012, American Journal of Transplantation. Peer-reviewed.
 
Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H., Glanville A.R., Klepetko W., Aboyoun C., Vettorazzi E., Lama R., Bravo C., Knoop C., Aubert J.D., Reichenspurner H. et al., 2012. Journal of Heart and Lung Transplantation, 31 (8) pp. 797-804.
 
Emotional experience in patients awaiting lung transplantation: A qualitative analysis
Bruegger A., Aubert John D., Piot-Ziegler C., 2011/09., the 15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics p. 193 dans Transplant International. Peer-reviewed.
 
The definition of quality of life in solid organ transplantation: A psychological qualitative model
Piot-Ziegler C., Aubert J.D., Pascual M., 2011/09., the 15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics p. 246 dans Transplant international. Peer-reviewed.
 
Respiratory Virus
Manuel O., 2011/05. pp. 55-58 dans Kumar D., Humar A. (eds.) The AST Handbook of Transplant Infections chap. 20, Wiley-Blackwell.
 
A model for organ donation in switzerland, the latin organ donation programme (lodp); an ongoing successful regional initiative
Moretti D., Heidegger C.P., Eckert P., Malacrida R., Pascual M., Revelly J.P., 2011. p. 153 dans 15th Congress of the European Society for Organ Transplantation and 22nd Annual Conference of the British Society for Histocompatibility and Immunogenetics, Transplant international. Peer-reviewed.
Challenges in lung transplantation.
Krueger T., Berutto C., Aubert J.D., 2011. Swiss Medical Weekly, 141 pp. w13292.
 
Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient.
Boillat Blanco N., Kuonen R., Bellini C., Manuel O., Estrade C., Mazza-Stalder J., Aubert J.D., Sahli R., Meylan P., 2011. Transplant Infectious Disease, 13 (2) pp. 213-215.
Diagnostic de la mort dans le contexte de la transplantation d'organes. Les directives.
Commission Centrale d'Ethique de l'ASSM, 2011. Bulletin des Médecins Suisses, 92 (32-33) pp. 1208-1210.
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.A., Venetz J.P., Calandra T., Cavassini M., 2011. Clinical Infectious Diseases, 52 (2) pp. 248-256.
Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells.
Muller Y.D., Golshayan D., Ehirchiou D., Wyss J.C., Giovannoni L., Meier R., Serre-Beinier V., Puga Yung G., Morel P., Bühler L.H. et al., 2011. Diabetes, 60 (9) pp. 2331-2340.
 
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N., Pascual M., Venetz J.P., Nseir G., Meylan P.R., Manuel O., 2011. Transplantation, 91 (2) pp. 251-255.
 
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
Lange C.M., Moradpour D., Doehring A., Lehr H.A., Müllhaupt B., Bibert S., Bochud P.Y., Antonino A.T., Pascual M., Farnik H. et al., 2011. Journal of Hepatology, 55 (2) pp. 322-327.
 
Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
Jankovic J., Pascual M., Venetz J.P., Nseir G., Meylan P., Manuel O., 2011. p. 323 dans ATC 2011, American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Letter by Nguyen regarding article, "acetaminophen increases blood pressure in patients with coronary artery disease".
Nguyen Q.V., 2011. Circulation, 123 (25) pp. e645.
 
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
Manuel O., Humar A., Berutto C., Ely L., Giulieri S., Lien D., Meylan P.R., Weinkauf J., Pascual M., Nador R. et al., 2011. Journal of Heart and Lung Transplantation, 30 (6) pp. 679-684.
 
Monitoring of CD4(+)CD25(high)IL-7R alpha(high) activated T Cells in Kidney Transplant Recipients
Vallotton L., Hadaya K., Venetz J.P., Buehler L.H., Ciuffreda D., Nseir G., Codarri L., Villard J., Pantaleo G., Pascual M., 2011. Clinical Journal of the American Society of Nephrology, 6 (8) pp. 2025-2033.
 
Overlapping Pathways to Transplant Glomerulopathy: Chronic Humoral Rejection, Hepatitis C Infection and Thrombotic Microangiopathy
Baid-Agrawal S., Farris A.B., Pascual M., Mauiyyedi S., Farrell M.L., Tolkoff-Rubin N., Collins A.B., Colvin R.B., 2011. p. 401 dans ATC 2011, American Transplant Congress, American Journal of Transplantation.
 
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.
Baid-Agrawal S., Farris A.B., Pascual M., Mauiyyedi S., Farrell M.L., Tolkoff-Rubin N., Collins A.B., Frei U., Colvin R.B., 2011. Kidney International, 80 (8) pp. 879-885.
 
Partager la vie : témoignages
Pascual M., 2011. pp. 160-173 dans Schneider P., Tissot J.D., Benzoni M., Ribes O. (eds.) Le sang : Arts, Sciences, Vie, Favre.
 
Prise en charge psychologique en transplantation d'organes : quel accompagnement pour les patients?
Piot-Ziegler C., Pascual M., 2011. Encyclopédie Médico-Chirurgicale, EMC pp. 1-44. Peer-reviewed.
 
Programme latin de don d'organes (PLDO): une initiative efficace pour augmenter les dons d'organes en Suisse [Latin organ donation programme (LODP): an effective initiative to increase organ donation in Switzerland].
Heidegger C.P., Moretti D., Eckert P., Malacrida R., Pascual M., Revelly J.P., 2011. Revue Médicale Suisse, 7 (300) pp. 1368-1371.
 
QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity.
Giulieri S., Manuel O., 2011. Expert Review of Molecular Diagnostics, 11 (1) pp. 17-25.
 
Renal transplantation following aorto-iliac reconstruction is a safe a strategy
Dubuis C., Deglise S., Saucy F., Saint-Lebes B., Venetz J.P., Pascual M., Corpataux J.M., 2011. p. 284 dans 15th Congress of the European Society for Organ Transplantation and 22nd Annual Conference of the British Society for Histocompatibility and Immunogenetics, Transplant international. Peer-reviewed.
 
Rituximab dans le traitement des maladies rénales glomérulaires: indications et evidences cliniques [Rationale and clinical evidence for the use of rituximab in glomerular diseases].
Mani L.Y., Vogt B., Burnier M., Golshayan D., 2011. Revue Médicale Suisse, 7 (290) pp. 819-824.
 
Sélection et suivi prétransplantation des patients candidats à la greffe cardiaque en Suisse romande [Selection and preoperative follow-up of heart transplantation candidates in the French part of Switzerland].
Yarol N., Tozzi P., von Segesser L., Kalangos A., Vogt P., Yerly P., Mach F., Pascual M., Meyer P., Hullin R., 2011. Revue Médicale Suisse, 7 (297) pp. 1212-1216.
 
Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.
Pilat N., Klaus C., Gattringer M., Jaeckel E., Wrba F., Golshayan D., Baranyi U., Wekerle T., 2011. Transplantation, 92 (3) pp. 280-288.
 
Transplantation tolerance: Clinical potential of regulatory T cells.
Muller Y.D., Seebach J.D., Bühler L.H., Pascual M., Golshayan D., 2011. Self/nonself, 2 (1) pp. 26-34.
 
Treatment of Recurrent Hepatitis C after Liver Transplantation with PEG-Interferon and Ribavirin.
Antonino A.T., Fontana M., Gioastra E., Moradpour D., Pascual M., 2011. pp. S149 dans Joint International Congress of ILTS (International Liver Transplantation Society), ELITA (European Society for Organ Transplantation) and LICAGE (Liver Intensive Care Group of Europe), Liver Transplantation. Peer-reviewed.
 
Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland.
Jackson Y., Dang T., Schnetzler B., Pascual M., Meylan P., 2011. Journal of Heart and Lung Transplantation, 30 (4) pp. 484-485.
 
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
Manuel O., Perrottet N., Pascual M., 2011. Expert Review of Anti-infective Therapy, 9 (11) pp. 955-965.
 
Recommandations suisses pour la prise en charge des cancers cutanés chez les patients transplantés d'organe [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]
Lapointe A.K., Hofbauer G., Anliker M., Arnold A., Binet I., Hunger R., Kempf W., Pascual M., Pelloni F., Serra A. et al., 2010/04/28. Revue medicale suisse, 6 (246) pp. 854-859.
 
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
Kumar D., Husain S., Chen M.H., Moussa G., Himsworth D., Manuel O., Studer S., Pakstis D., McCurry K., Doucette K. et al., 2010/04/27. Transplantation, 89 (8) pp. 1028-1033. Peer-reviewed.
Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation.
Muller Y.D., Mai G., Morel P., Serre-Beinier V., Gonelle-Gispert C., Yung G.P., Ehirchiou D., Wyss J.C., Bigenzahn S., Irla M. et al., 2010/04/26. PloS one, 5 (4) pp. e10352. Peer-reviewed.
Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.
Uçkay I., Gasche-Soccal P.M., Kaiser L., Stern R., Mazza-Stalder J., Aubert J.D., van Delden C., 2010/03. The Journal of heart and lung transplantation, 29 (3) pp. 299-305. Peer-reviewed.
 
A Randomized Controlled Trial Comparing Intradermal vs. Intramuscular Influenza Vaccine in Lung Transplant Recipients
Manuel O, Humar A., Berutto C., Lien D., Giulieri S., Weinkauf J., Meylan P.R., Ely L., Pascual M., Nador R. et al., 2010. p. 208 dans 10th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Aortic remodelling in Fabry disease
Barbey F., Qanadli S.D., Juli C., Brakch N., Palacek T., Rizzo E., Jeanrenaud X., Eckhardt B., Linhart A., 2010. European Heart Journal, 31 (3) pp. 347-353. Peer-reviewed.
 
Autophagosome maturation is impaired in Fabry disease.
Chevrier Marc, Brakch Noureddine, Lesueur Celine, Genty Damien, Ramdani Yasmina, Moll Solange, Djavaheri-Mergny Mojgan, Brasse-Lagnel Carole, Laquerriere Annie, Barbey Frederic et al., 2010. Autophagy, 6 (5) pp. 589-599.
 
Bosentan and/or Sildenafil for non-operable chronic thromboembolic pulmonary hypertension
Langenskioeld E., Bonetti A., Nicod L.P., Aubert J.-D., 2010. p. 12 dans Joint annual meeting of the Swiss Society of Pneumology, Swiss Society of Pediatric Pneumology, Swiss Society for Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Comparison of three antigenic extracts of Eurotium amstelodami in serological diagnosis of farmer's lung disease.
Roussel Sandrine, Reboux Gabriel, Rognon Benedicte, Monod Michel, Grenouillet Frederic, Quadroni Manfredo, Fellrath Jean-Marc, Aubert John-David, Dalphin Jean-Charles, Millon Laurence, 2010. Clinical and Vaccine Immunology, 17 (1) pp. 160-167.
 
Differential effects of immunosuppressive drugs on effector and regulatory T cells.
Wyss J.C., Mottet C., Lechler R., Pascual M., Golshayan D., 2010. pp. 7S-8S dans Annual Meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Differential role of naïve and memory CD4 T-cell subsets in primary alloresponses.
Golshayan D., Wyss J.C., Buckland M., Hernandez-Fuentes M., Lechler R.I., 2010. American Journal of Transplantation, 10 (8) pp. 1749-1759.
 
Does Influenza Vaccination Induce De Novo HLA Alloantibody Formation in Transplant Recipients?
Kumar D., Bergeron A., Humar A., Hidalgo L., Manuel O., Campbell P., 2010. pp. 207-208 dans 10th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor.
Mueller N.J., Weisser M., Fehr T., Wüthrich R.P., Müllhaupt B., Lehmann R., Imhof A., Aubert J.D., Genoni M., Kunz R. et al., 2010. Transplant Infectious Disease, 12 (1) pp. 54-59.
Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease.
Brakch N., Dormond O., Bekri S., Golshayan D., Correvon M., Mazzolai L., Steinmann B., Barbey F., 2010. European Heart Journal, 31 (1) pp. 67-76.
 
Ganciclovir exposure under a 450mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Meylan P.R., 2010. Clinical Transplantation, 24 (6) pp. 794-800.
 
Giant warts in a kidney transplant patient: regression with sirolimus.
Kostaki M., Venetz J.P., Nseir G., Meylan P., Sahli R., Pascual M., Laffitte E., 2010. British Journal of Dermatology, 162 (5) pp. 1148-1150.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University